CSL and Arcturus’ KOSTAIVE® Self-amplifying mRNA COVID-19 Vaccine Approved by European Commission

CSL and Arcturus’ KOSTAIVE® Self-amplifying mRNA COVID-19 Vaccine Approved by European Commission CSL (ASX: CSL; USOTC: CSLLY), a global biotechnology leader, and Arcturus Therapeutics (Nasdaq: ARCT), a pioneer in self-amplifying mRNA (sa-mRNA) technology, have announced that the European Commission has…

Read MoreCSL and Arcturus’ KOSTAIVE® Self-amplifying mRNA COVID-19 Vaccine Approved by European Commission

Galderma’s Nemluvio® (Nemolizumab) EU Approval for Atopic Dermatitis and Prurigo Nodularis

Galderma’s Nemluvio® (Nemolizumab) EU Approval for Atopic Dermatitis and Prurigo Nodularis Galderma announced that the European Commission has granted approval for Nemluvio® (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio, a…

Read MoreGalderma’s Nemluvio® (Nemolizumab) EU Approval for Atopic Dermatitis and Prurigo Nodularis

QIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific

QIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has officially opened a new data center in Melbourne, Australia, reinforcing its leadership in global bioinformatics, particularly in the Asia-Pacific region. This new…

Read MoreQIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific

Prolific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth

Prolific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth Prolific Machines, a leading biotechnology company specializing in using light to control biological processes, has announced the appointment of Christina Perry as its new Chief Financial Officer (CFO). In…

Read MoreProlific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth